title: Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses.
abstract: "HIV controllers" (HICs) are rare individuals in whom HIV-1 plasma viral load remains undetectable without antiretroviral treatment. This spontaneous viral control in HICs is usually associated to strong functional HIV-specific CD8(+) T cell responses. Accordingly, we have recently shown that CD8(+) T cells from HICs strongly suppress ex vivo HIV-1 infection of autologous CD4(+) T cells, suggesting a crucial role of this response in vivo. Knowledge of the mechanisms underlying the CD8(+) T cell antiviral activity might help to develop effective T cell-based vaccines. In the present work, we further characterized the HIV-suppressive capacity of CD8(+) T cells in 19 HICs. CD8(+) T cells from 14 of the 19 HICs showed strong HIV-suppressive capacity ex vivo. This capacity was stable over time and was partially effective even on other primate lentiviruses. HIV-suppressive capacity of CD8(+) T cells correlated strongly with the frequency of HIV-specific CD8(+) T cells, and in particular of Gag-specific CD8(+) T cells. We also identified five HICs who had weak HIV-suppressive CD8(+) T cell capacities and HIV-specific CD8(+) T cell responses. Among these five HICs, at least three had highly in vitro replicative viruses, suggesting that the control of viremia in these patients is not due to replication-defective viruses. These results, on the one hand, suggest the importance of Gag responses in the antiviral potency of CD8(+) T cells from HICs and, on the other hand, propose that other host mechanisms may contribute to restraining HIV infection in HICs.
authors.affiliation: Institut Pasteur, Unité de Régulation des Infections Rétrovirales, Paris, France.
authors.forename: Asier
authors.initials: A
authors.lastname: Sáez-Cirión
authors.forename: Martine
authors.initials: M
authors.lastname: Sinet
authors.forename: So Youn
authors.initials: SY
authors.lastname: Shin
authors.forename: Alejandra
authors.initials: A
authors.lastname: Urrutia
authors.forename: Pierre
authors.initials: P
authors.lastname: Versmisse
authors.forename: Christine
authors.initials: C
authors.lastname: Lacabaratz
authors.forename: Faroudy
authors.initials: F
authors.lastname: Boufassa
authors.forename: Véronique
authors.initials: V
authors.lastname: Avettand-Fènoël
authors.forename: Christine
authors.initials: C
authors.lastname: Rouzioux
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Delfraissy
authors.forename: Françoise
authors.initials: F
authors.lastname: Barré-Sinoussi
authors.forename: Olivier
authors.initials: O
authors.lastname: Lambotte
authors.forename: Alain
authors.initials: A
authors.lastname: Venet
authors.forename: Gianfranco
authors.initials: G
authors.lastname: Pancino
mesh_terms: D000328:Adult; D000368:Aged; D018414:CD8-Positive T-Lymphocytes / Q000201:enzymology* / Q000378:metabolism*; D002478:Cells, Cultured; D005260:Female; D015683:Gene Products, gag / Q000235:genetics / Q000276:immunology* / Q000378:metabolism*; D018740:Genetic Heterogeneity; D015658:HIV Infections / Q000235:genetics / Q000276:immunology* / Q000378:metabolism*; D015497:HIV-1 / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis / Q000276:immunology; D008297:Male; D008875:Middle Aged; D014779:Virus Replication
chemical_list: D015683:Gene Products, gag; D007371:Interferon-gamma